It is a financial services public limited company based in Mumbai, Maharashtra, India, established in 1994.
1994 | Mumbai, Maharashtra, India | ActiveM.C.Shroff Pharmaceuticals Limited, a active public limited company, was established on 24 January 1994 in Mumbai, Maharashtra, India. Engaging in auxiliary to financial intermediatory within the financial services sector, it holds CIN: U67120MH1994PLC076216. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Swati Ramesh Shroff (Director), Ramesh Menghraj Shroff (Director), Karan Ramesh Shroff (Director). Past directors included Raj Menghraj Shroff, Swati Ramesh Shroff, Karan Ramesh Shroff. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 106 Kamal Bldg., C Bldg.,Agarwal Market,Vile Parle,, Mumbai, Maharashtra, 400057.
U67120MH1994PLC076216
076216
24 January 1994
₹1.00 Cr
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into M.C.Shroff Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swati Ramesh Shroff | Director | 10 Aug 2018 | Current |
| Ramesh Menghraj Shroff | Director | 24 Jan 1994 | Current |
| Karan Ramesh Shroff | Director | 10 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Aug 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 10 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
M.C.Shroff Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, M.C.Shroff Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with M.C.Shroff Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of M.C.Shroff Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M.C.Shroff Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity M.C.Shroff Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
M.C.Shroff Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Swati Ramesh Shroff was appointed as a Director was appointed as a Director on 10 Aug 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.
The activity Karan Ramesh Shroff was appointed as a Director was appointed as a Director on 10 Aug 2018 & has been associated with this company since 7 years 3 months . was completed.
The activity Ramesh Menghraj Shroff was appointed as a Director was appointed as a Director on 24 Jan 1994 & has been associated with this company since 31 years 10 months . was completed.
The activity M.C.Shroff Pharmaceuticals Limited was registered on 24 Jan 1994 with Roc Mumbai & aged 31 years 10 months as per MCA records. was completed.
The CIN of M.C.Shroff Pharmaceuticals Limited is U67120MH1994PLC076216.
M.C.Shroff Pharmaceuticals Limited is headquartered at 106 Kamal Bldg., C Bldg.,Agarwal Market,Vile Parle,, Mumbai, Maharashtra, 400057.
M.C.Shroff Pharmaceuticals Limited was incorporated on 24 January 1994.
The current directors of M.C.Shroff Pharmaceuticals Limited are
The primary industry of M.C.Shroff Pharmaceuticals Limited is Financial Services.
M.C.Shroff Pharmaceuticals Limited is unlisted.
The authorized capital of M.C.Shroff Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹0.50 M.
The compliance status of M.C.Shroff Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX